502 related articles for article (PubMed ID: 15356567)
21. Add-on montelukast in antihistamine-resistant chronic idiopathic urticaria.
Kosnik M; Subic T
Respir Med; 2011 Oct; 105 Suppl 1():S84-8. PubMed ID: 22015095
[TBL] [Abstract][Full Text] [Related]
22. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis.
Pinar E; Eryigit O; Oncel S; Calli C; Yilmaz O; Yuksel H
Auris Nasus Larynx; 2008 Mar; 35(1):61-6. PubMed ID: 17826020
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and safety of desloratadine 5 mg once daily in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled trial.
Monroe E; Finn A; Patel P; Guerrero R; Ratner P; Bernstein D;
J Am Acad Dermatol; 2003 Apr; 48(4):535-41. PubMed ID: 12664016
[TBL] [Abstract][Full Text] [Related]
24. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial.
Meltzer EO; Malmstrom K; Lu S; Prenner BM; Wei LX; Weinstein SF; Wolfe JD; Reiss TF
J Allergy Clin Immunol; 2000 May; 105(5):917-22. PubMed ID: 10808172
[TBL] [Abstract][Full Text] [Related]
25. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
[TBL] [Abstract][Full Text] [Related]
26. The effectiveness of montelukast for the treatment of anti-histamine-resistant chronic urticaria.
Sanada S; Tanaka T; Kameyoshi Y; Hide M
Arch Dermatol Res; 2005 Sep; 297(3):134-8. PubMed ID: 16044256
[TBL] [Abstract][Full Text] [Related]
27. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis.
Pleskow W; Grubbe R; Weiss S; Lutsky B
Ann Allergy Asthma Immunol; 2005 Mar; 94(3):348-54. PubMed ID: 15801245
[TBL] [Abstract][Full Text] [Related]
28. Montelukast treatment of urticaria.
McBayne TO; Siddall OM
Ann Pharmacother; 2006 May; 40(5):939-42. PubMed ID: 16670370
[TBL] [Abstract][Full Text] [Related]
29. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma.
Baena-Cagnani CE; Berger WE; DuBuske LM; Gurné SE; Stryszak P; Lorber R; Danzig M
Int Arch Allergy Immunol; 2003 Apr; 130(4):307-13. PubMed ID: 12740532
[TBL] [Abstract][Full Text] [Related]
30. Premedication with montelukast reduces local reactions of allergen immunotherapy.
Wöhrl S; Gamper S; Hemmer W; Heinze G; Stingl G; Kinaciyan T
Int Arch Allergy Immunol; 2007; 144(2):137-42. PubMed ID: 17536222
[TBL] [Abstract][Full Text] [Related]
31. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine.
Ciebiada M; Barylski M; Gorska Ciebiada M
Am J Rhinol Allergy; 2013; 27(2):e58-62. PubMed ID: 23562192
[TBL] [Abstract][Full Text] [Related]
32. Desloratadine therapy for symptoms associated with perennial allergic rhinitis.
Kim K; Sussman G; Hébert J; Lumry W; Lutsky B; Gates D
Ann Allergy Asthma Immunol; 2006 Mar; 96(3):460-5. PubMed ID: 16597081
[TBL] [Abstract][Full Text] [Related]
33. Efficacy of diphenhydramine vs desloratadine and placebo in patients with moderate-to-severe seasonal allergic rhinitis.
Raphael GD; Angello JT; Wu MM; Druce HM
Ann Allergy Asthma Immunol; 2006 Apr; 96(4):606-14. PubMed ID: 16680933
[TBL] [Abstract][Full Text] [Related]
34. Loratadine and montelukast administered in combination produce decongestion in an experimental feline model of nasal congestion.
McLeod RL; Mingo GG; Xu X; Palamanda J; Hunter JC; Jia Y
Am J Rhinol Allergy; 2009; 23(6):e17-22. PubMed ID: 19769798
[TBL] [Abstract][Full Text] [Related]
35. Effect of levothyroxine treatment on clinical symptoms and serum cytokine levels in euthyroid patients with chronic idiopathic urticaria and thyroid autoimmunity.
Kiyici S; Gul OO; Baskan EB; Hacioglu S; Budak F; Erturk E; Imamoglu S
Clin Exp Dermatol; 2010 Aug; 35(6):603-7. PubMed ID: 19874329
[TBL] [Abstract][Full Text] [Related]
36. Quality of life in patients with persistent allergic rhinitis treated with desloratadine monotherapy or desloratadine plus montelucast combination.
Erdoğan BA; Sanlı A; Paksoy M; Altın G; Aydın S
Kulak Burun Bogaz Ihtis Derg; 2014; 24(4):217-24. PubMed ID: 25046070
[TBL] [Abstract][Full Text] [Related]
37. Montelukast plus cetirizine in the prophylactic treatment of seasonal allergic rhinitis: influence on clinical symptoms and nasal allergic inflammation.
Kurowski M; Kuna P; Górski P
Allergy; 2004 Mar; 59(3):280-8. PubMed ID: 14982509
[TBL] [Abstract][Full Text] [Related]
38. The combination of single-dose montelukast and loratadine on exercise-induced bronchospasm in children.
Peroni DG; Piacentini GL; Pietrobelli A; Loiacono A; De Gasperi W; Sabbion A; Micciolo R; Boner AL
Eur Respir J; 2002 Jul; 20(1):104-7. PubMed ID: 12166555
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, placebo-controlled trial of montelukast in adult atopic eczema.
Friedmann PS; Palmer R; Tan E; Ogboli M; Barclay G; Hotchkiss K; Berth-Jones J
Clin Exp Allergy; 2007 Oct; 37(10):1536-40. PubMed ID: 17850382
[TBL] [Abstract][Full Text] [Related]
40. The effect of montelukast (10mg daily) and loratadine (10mg daily) on wheal, flare and itching reactions in skin prick tests.
Kupczyk M; Kupryś I; Górski P; Kuna P
Pulm Pharmacol Ther; 2007; 20(1):85-9. PubMed ID: 16516511
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
